Trending Now
Pardes Bioscience Inc. (NASDAQ: PRDS) Presents Late-Breaker Poster on PBI-451 Phase...
Pardes Bioscience Inc. (NASDAQ: PRDS) has announced a late-breaker poster presentation sharing clinical findings from the current PBI-0451 Phase 1 study to be presented...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
180 Life Sciences Corp (NASDAQ: ATNF) and The University of Oxford...
The University of Oxford and 180 Life Sciences Corp (NASDAQ: ATNF) received their results from the Phase IIb study of adalimumab. The parties had...
MAKE IT MODERN
LATEST REVIEWS
HOOKIPA Pharma Inc. (OTCMKTS: HOOK) Announce Restatement and Amendment of Partnership...
HOOKIPA Pharma Inc. (OTCMKTS: HOOK) has announced the signing of a restated and amended partnership and license deal with Gilead to develop proprietary arenaviral...
MAKE IT MODERN
PERFORMANCE TRAINING
Evofem Biosciences Inc (NASDAQ:EVFM) Inks A Pact With NCODA To Help Women With Cancer...
Evofem Biosciences Inc (NASDAQ:EVFM) signed a collaboration agreement with the National Community Oncology Dispensing Association, Inc (NCODA) to improve the lives of women suffering...
Amarin Corporation Plc (NASDAQ:AMRN) Reports A Growth Of 34% YoY In Q2 2020 Revenues:...
Amarin Corporation Plc (NASDAQ:AMRN) posted revenues of $135.3 million in Q2 2020. President of Amarin, John F. Thero said Q2 2020 is a challenging...
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks Investor Excitement”
Exciting times are on the horizon for investors and traders closely following Mesoblast Limited (NASDAQ:MESO), as recent communications with the FDA suggest...
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) Enrols the first Patient in Study Evaluating BCX9930’s Therapeutic...
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) has announced that it has enrolled the first subject in its RENEW proof-of-concept basket trial with its oral Factor...
Stocks that Wall Street is watching (VERI, WATT, YAYO)
Few key resistance and support lines have set up and we continue to bounce between them in the premarket.
MAKE IT MODERN
